Medesis Pharma
  • en
  • fr
  • Corporate
    • General presentation
    • Historical
    • Governance
    • Supervisory board
    • Scientific Advisory board
  • Technology
    • Description
    • Advantages
    • Historical
  • Pipeline
  • Clinical
    • Alzheimer’s disease
  • Pre-clinical
    • Neurology
    • Cancer
    • Nuclear
  • Investors
    • Share information
    • Press release
    • Reports and documents
    • Regulated information
    • General Meetings
    • Agenda & Contact
  • Scientific publications
  • Contacts
Select Page
Investors

Investors

by Calyptus | Jan 26, 2021 | Investors, Non classé

Successful IPO of MEDESIS PHARMA, a biotechnology pharmaceutical company, on Euronext Growth Paris® (ISIN: FR0010844464, MNEMO: ALMDP). Visit the Investors section for more information

Recent Posts

  • Alzheimer’s disease
  • We develop new drugs to preserve life
  • Investors
  • Medesis Pharma & Transgene prolongent leur accord de recherche collaborative
  • NanoSIRNA

Recent Comments

    Archives

    • August 2021
    • June 2021
    • January 2021
    • November 2020
    • March 2020
    • July 2019
    • October 2017
    • September 2017
    • July 2017
    • June 2017

    Categories

    • Banner in one
    • Clinical stage products
    • In one
    • Investors
    • Non classé
    • Preclinical stage product
    • Press news
    • Research
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Facebook
    • Twitter
    • Instagram
    • RSS

    Designed by Elegant Themes | Powered by WordPress

    Manage Cookie Consent
    We use cookies to optimize our website and our service. Cookie Policy
    Functional Always active
    The storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication on an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Marketing
    The technical storage or access that is used exclusively for statistical purposes. Technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance by your ISP, or additional third-party records, information stored or retrieved for this purpose alone generally cannot be used to identify you.
    Marketing
    Storage or technical access is required to create user profiles to send advertising, or to track the user across one or multiple websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    Personalize
    {title} {title} {title}